News

Are We Ready for a Blood Test for Cancer?

Are We Ready for a Blood Test for Cancer?

January 22, 2016

What if screening for cancer was as easy as checking your cholesterol? That’s the promise of techniques currently in development that may one day make it possible to detect the earliest stages of cancer with an annual blood draw.
 
E-cigarettes, as Used, Aren’t Helping Smokers Quit, Study Shows

E-cigarettes, as Used, Aren’t Helping Smokers Quit, Study Shows

January 15, 2016

Electronic cigarettes are widely promoted and used to help smokers quit traditional cigarettes, but a new analysis from UC San Francisco found that adult smokers who use e-cigarettes are actually 28 percent less likely to stop smoking cigarettes.

NCCN Awards Research Grants to Five Investigators to Study Effectiveness of Enzalutamide in Various Cancers

NCCN Awards Research Grants to Five Investigators to Study Effectiveness of Enzalutamide in Various Cancers

January 13, 2016

The NCCN Oncology Research Program has awarded five research grants to investigate the effectiveness of enzalutamide in mantle cell lymphoma and endometrial, hepatocellular, and prostate cancers.

Biochemist James Wells Among 12 UC Innovators Elected to National Academy of Inventors

Biochemist James Wells Among 12 UC Innovators Elected to National Academy of Inventors

December 18, 2015

Thirteen University of California innovators have been elected as fellows to the prestigious National Academy of Inventors for work that is transforming semiconductor manufacturing, boosting the efficiency of biofuels and saving lives through the creation of new biomedical technologies.The newest UC members of the ...
image

Researchers Create Cellular “ORACLs” to Aid Drug Discovery

December 14, 2015

A team of researchers at UC San Francisco has devised a new approach for early stage drug discovery that uses techniques from the world of computer vision in combination with a powerful new tool: a lineage of genetically modified cancer cells in a dish that change their appearance when treated with drugs targeting common disease pathways.

UCSF Speakers Announced for 2016 Personalized Medicine World Conference

UCSF Speakers Announced for 2016 Personalized Medicine World Conference

December 9, 2015

The lineup is finalized for the 2016 Personalized Medicine World Conference, with nine scheduled talks by UCSF leaders and faculty.

image

‘Purity’ Of Tumor Samples May Significantly Bias Genomic Analyses

December 4, 2015

A new study by UC San Francisco scientists shows that the proportion of normal cells, especially immune cells, intermixed with cancerous cells in a given tissue sample may significantly skew the results of genetic analyses and other tests performed both by researchers and by physicians ...
Keith Yamamoto Named UCSF’s First Vice Chancellor of Science Policy and Strategy

Keith Yamamoto Named UCSF’s First Vice Chancellor of Science Policy and Strategy

November 24, 2015

Keith Yamamoto, PhD, has spent his career doing basic research, and also working both to improve the practice of science and to amplify its impact beyond the walls of academia. Now, in his new role as UCSF’s first vice chancellor for Science Policy and Strategy, he’ll lead efforts to anticipate the needs of an increasingly dynamic biomedical research endeavor, and to position UCSF optimally, both by working within the University and by influencing and shaping science policy at the state and national levels and beyond.

Nobel Laureate Elizabeth Blackburn Named President of Salk Institute

Nobel Laureate Elizabeth Blackburn Named President of Salk Institute

November 18, 2015

Nobel laureate Elizabeth Blackburn, PhD, professor of biochemistry and biophysics at UC San Francisco, has been named the first woman president of the Salk Institute for Biological Sciences.

New Sean N. Parker Autoimmune Research Laboratory is Launched at UCSF

New Sean N. Parker Autoimmune Research Laboratory is Launched at UCSF

November 17, 2015

A $10 million gift from The Parker Foundation, founded by Silicon Valley entrepreneur and philanthropist Sean Parker, will establish a new research laboratory within the Diabetes Center at UC San Francisco devoted to understanding autoimmunity, in the hopes of laying the groundwork for new treatments for diseases ranging from type 1 diabetes to multiple sclerosis to rheumatoid arthritis.